High-Dose Cytarabine Neurological Assessment Tool

Introduction

The use of high doses of Cytarabine (HD araC) is associated with neurological changes that can result in long-term complications. According to Dantoni (2013), the incidence of neurotoxicity in patients undergoing chemotherapy with HD araC is 7 percent to 28 percent. The aim of this paper is to discuss the practicum project on the development of a new neurological assessment instrument for patients receiving HD araC.

Discussion

The goal of the development of a new tool for neurological assessment of patients undergoing HD araC treatment was successfully accomplished. The instrument completely changes the current nursing practice by providing health care professionals with the ability to quickly recognize neurological symptoms and provide timely intervention for the group of patients who are vulnerable to neurotoxicity.

Prompt recognition of changes in cognitive status and cerebellar function of patients is extremely important because “the incorporation of cytarabine into DNA and RNA may contribute to cerebral toxicity” (BC Cancer Agency, n.d., para. 1). Neurotoxic effects are usually evident 3 to 8 days after the initiation of therapy (BC Cancer Agency, n.d.). The use of the handwriting tool allows nurses to perform the neurological assessment in the clinical setting, thereby reducing the negative health care outcomes of their patients.

The process of working on the project was a positive experience because it allowed me to exercise my research and analytic skills. During the early stages of project development, I found it difficult to allocate reasonable timescales for the anticipated delivery. However, after establishing all research activities that had to be performed, I realized that my knowledge of scientific research tools and methods would help me to successfully finish the project cycle. I also knew that the two SMART goals were aligned with Baptist Health of South Florida’s culture of “generosity, compassion and commitment to clinical and service excellence” (Baptist Health of South Florida, n.d., para. 2).

Furthermore, the international reputation of the hospital attracts approximately 12, 000 patients from Latin America and Caribbean; therefore, I was happy to develop a tool that could help to preserve a high standing of the health center (Baptist Health of South Florida, n.d.). It can be said that the project was a highly rewarding learning experience for me.

A comprehensive overview of the requirements of the practicum project allowed me to evaluate my resources and to compare them to the desired outcomes. I realized that the project was outside of my competency network, which meant that I had to conduct an extensive research on cancer patient populations as well as the use of handwriting tools for the assessment of neurological disorders in order to add breath to my knowledge portfolio (Singh, Mehta, Shah, & Mehta, 2016). Open lines of communication with the faculty were beneficial to the completion of the project.

Face-to-face meetings with a navigator allowed me not only to successfully finish the project but also to contribute value to my organization. The navigator helped me to effectively utilize my skills and knowledge as well as to demonstrate self-direction, which resulted in the absence of delays in the completion of the project (Ciocco, 2015; Sipes, 2015).

Conclusion

The development of the new neurological assessment instrument for patients receiving HD araC was a positive learning experience for me. I was able to utilize my knowledge and skills as well as to add breath to my competency network.

References

Baptist Health of South Florida. (n.d.). About Baptist Health South Florida. Web.

BC Cancer Agency, (n.d.). Drug name: Cytarabine. Web.

Ciocco, M. (2015). Fast facts for the nurse preceptor: Keys to providing a successful preceptorship in a nutshell. New York, NY: Springer.

Dantoni, T. (2013). High dose Cytarabine: Neurological assessment guide streamlines symptom documentation. 

Singh, G., Mehta, R., Shah, N., & Mehta, R. (2016). Handwriting change as a psychiatric symptom. The International Journal of Medical and Dental Sciences, 5(1), 1075-1077.

Sipes, C. (2015). Project management for the advanced practice nurse. New York, NY: Springer.

Cite this paper

Select style

Reference

StudyCorgi. (2020, November 23). High-Dose Cytarabine Neurological Assessment Tool. https://studycorgi.com/high-dose-cytarabine-neurological-assessment-tool/

Work Cited

"High-Dose Cytarabine Neurological Assessment Tool." StudyCorgi, 23 Nov. 2020, studycorgi.com/high-dose-cytarabine-neurological-assessment-tool/.

* Hyperlink the URL after pasting it to your document

References

StudyCorgi. (2020) 'High-Dose Cytarabine Neurological Assessment Tool'. 23 November.

1. StudyCorgi. "High-Dose Cytarabine Neurological Assessment Tool." November 23, 2020. https://studycorgi.com/high-dose-cytarabine-neurological-assessment-tool/.


Bibliography


StudyCorgi. "High-Dose Cytarabine Neurological Assessment Tool." November 23, 2020. https://studycorgi.com/high-dose-cytarabine-neurological-assessment-tool/.

References

StudyCorgi. 2020. "High-Dose Cytarabine Neurological Assessment Tool." November 23, 2020. https://studycorgi.com/high-dose-cytarabine-neurological-assessment-tool/.

This paper, “High-Dose Cytarabine Neurological Assessment Tool”, was written and voluntary submitted to our free essay database by a straight-A student. Please ensure you properly reference the paper if you're using it to write your assignment.

Before publication, the StudyCorgi editorial team proofread and checked the paper to make sure it meets the highest standards in terms of grammar, punctuation, style, fact accuracy, copyright issues, and inclusive language. Last updated: .

If you are the author of this paper and no longer wish to have it published on StudyCorgi, request the removal. Please use the “Donate your paper” form to submit an essay.